Fernando Alberto Goldbaum

Title: Innovations by Fernando Alberto Goldbaum

Introduction

Fernando Alberto Goldbaum is a notable inventor based in Buenos Aires, Argentina. He has made significant contributions to the field of biotechnology, particularly through his innovative work on chimeric proteins. His research has implications for vaccine development and immune response induction.

Latest Patents

Goldbaum holds a patent for "Isolated chimeric proteins of modified lumazine synthase." This patent includes isolated chimeric proteins that consist of up to ten copies of peptides, polypeptides, or protein domains inserted into the amino termini of the lumazine synthase enzyme. The patent also covers isolated nucleotide sequences that code for these chimeric proteins, as well as vectors, plasmids, and transformed cells used for expressing the proteins. Additionally, it includes monoclonal and polyclonal antibodies induced by the chimeric proteins, hybridomas producing these antibodies, and various applications such as vaccines and pharmaceutical compounds. The patent outlines a method to induce an immune response in higher organisms through the administration of effective amounts of the vaccines and pharmaceutical compounds. Furthermore, it discusses the use of biosensors that incorporate the chimeric proteins and protein conjugates formed by the chimeric proteins and ligands.

Career Highlights

Goldbaum is associated with Goldgene LLC, where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in medical and biotechnological fields.

Collaborations

He has collaborated with notable colleagues, including Diego Andrés Laplagne and Vanesa Zylberman, contributing to a dynamic research environment.

Conclusion

Fernando Alberto Goldbaum's innovative work in the field of biotechnology, particularly with chimeric proteins, showcases his commitment to advancing medical science. His contributions have the potential to impact vaccine development and immune response strategies significantly.